Clinical Trials in Philadelphia

Showing 19201-19220 of 20,904 trials

Efficacy and Safety Evaluation of Pegamotecan (PEG-camptothecin) in Advanced or Metastatic Soft Tissue Sarcoma

NCT00079950

The purpose of this study is to evaluate the safety and efficacy of Pegamotecan (Peg-Camptothecin) in patients with Advanced or Metastatic Soft Tissue sarcoma.

Sarcoma, Soft Tissue

Enzon Pharmaceuticals, Inc.Started Aug 2003

Los Angeles, California, United States • Philadelphia, Pennsylvania, United States • Pittsburgh, Pennsylvania, United States +1 more locations

COMPLETEDPhase 2< 1 mile

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

NCT00941798

Study CQMF149A2210 evaluated the safety of QMF149 Twisthaler® 500/400 μg, a fixed dose combination of indacaterol 500 μg, a once daily β2 agonist, and mometasone furoate 400 μg, an inhaled corticosteroid (ICS) that is approved for use in the treatment of asthma. The objective of this safety trial was to assess the effect of treatment on the incidence of serious asthma exacerbations, defined as asthma related hospitalization and/or intubation and/or death. This was an event driven trial.

Asthma

Novartis Pharmaceuticals2,283 participantsStarted Jul 2009

Birmingham, Alabama, United States • Buena Park, California, United States • Encinitas, California, United States +143 more locations

Efficacy and Safety Evaluation of Pegamotecan (PEG-camptothecin) in Advanced or Metastatic Soft Tissue Sarcoma

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Find Trials by Condition in Philadelphia

An Efficacy Study Comparing SYMBICORT® Pressurised Metered Dose Inhaler (pMDI) With Budesonide Hydrofluoroalkanes (HFA) pMDI, in Hispanic Subjects With ICS Dependent Asthma

Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy

Safety and Efficacy of Lansoprazole 30mg Twice Daily in Treatment of Laryngitis Associated With Gastroesophageal Reflux

Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma

A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer

CMA-676 in Treating Older Patients With Acute Myeloid Leukemia in First Relapse

Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Low Back Pain

Ultrasound Visualization Versus Electrical Nerve Stimulation

Safety and Efficacy of Buprenorphine Transdermal System in Subjects With Moderate to Severe Osteoarthritis of Hip or Knee

Pilot Study of Docetaxel & Bevacizumab +/- Trastuzumab in First-Line Treatment of Patients With Metastatic Breast Cancer

EXPRESS: Examining Pagoclone for Persistent Developmental Stuttering Study

S9804: Vinorelbine in Treating Patients With Stage IV Melanoma

SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma

A Study Evaluating the Bioavailability of Two Formulations of Linifanib and Food Effect on Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors

S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

Safety and Efficacy of Dose Conversion From Vicodin® to Buprenorphine Transdermal System (Butrans™) in Subjects With OA Pain

Erlotinib in Treating Patients With Breast Cancer That Can Be Removed by Surgery

Comparison of Prasugrel and Clopidogrel in Low Body Weight Versus Higher Body Weight With Coronary Artery Disease